Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

CRNX is expected to report earnings to fall 6.53% to -87 cents per share on November 12

Crinetics Pharmaceuticals CRNX Stock Earnings Reports

Q3'24

Est.

$-0.88

Q2'24

Missed

by $0.08

Q1'24

Missed

by $0.13

Q4'23

Missed

by $0.04

Q3'23

Missed

by $0.14

The last earnings report on August 08 showed earnings per share of -93 cents, missing the estimate of -86 cents. With 370.62K shares outstanding, the current market capitalization sits at 4.06B.

View a ticker or compare two or three

Compare

CRNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRNX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CRNX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

6055 Lusk Boulevard

Phone

+1 858 450-6464

Employees

290

Web

https://www.crinetics.com